KR102660565B1 - Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof - Google Patents
Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof Download PDFInfo
- Publication number
- KR102660565B1 KR102660565B1 KR1020240015399A KR20240015399A KR102660565B1 KR 102660565 B1 KR102660565 B1 KR 102660565B1 KR 1020240015399 A KR1020240015399 A KR 1020240015399A KR 20240015399 A KR20240015399 A KR 20240015399A KR 102660565 B1 KR102660565 B1 KR 102660565B1
- Authority
- KR
- South Korea
- Prior art keywords
- wild ginseng
- hours
- extract composition
- ginsenoside
- present
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 235000008434 ginseng Nutrition 0.000 title claims abstract description 40
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 title claims abstract description 39
- 235000003140 Panax quinquefolius Nutrition 0.000 title claims abstract description 39
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 title claims abstract description 31
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 title claims abstract description 29
- 241000208340 Araliaceae Species 0.000 title claims abstract 5
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 title claims description 10
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 title claims description 10
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 title claims description 10
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title description 8
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 238000000605 extraction Methods 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000010992 reflux Methods 0.000 claims description 6
- 235000013361 beverage Nutrition 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 2
- 229930003268 Vitamin C Natural products 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 229940107702 grapefruit seed extract Drugs 0.000 claims description 2
- 238000000227 grinding Methods 0.000 claims description 2
- 235000019154 vitamin C Nutrition 0.000 claims description 2
- 239000011718 vitamin C Substances 0.000 claims description 2
- 238000010298 pulverizing process Methods 0.000 claims 1
- 238000007873 sieving Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 abstract description 9
- 239000002537 cosmetic Substances 0.000 abstract description 7
- 235000013376 functional food Nutrition 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract description 2
- 240000004371 Panax ginseng Species 0.000 description 35
- 230000000052 comparative effect Effects 0.000 description 24
- 239000000243 solution Substances 0.000 description 22
- 230000002292 Radical scavenging effect Effects 0.000 description 14
- 238000003809 water extraction Methods 0.000 description 12
- 229930182494 ginsenoside Natural products 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 9
- 229940089161 ginsenoside Drugs 0.000 description 9
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 8
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 7
- 238000002835 absorbance Methods 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 241000283707 Capra Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- OCZVHBZNPVABKX-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine;ethanol Chemical compound CCO.[O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 OCZVHBZNPVABKX-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- -1 ABTS cation Chemical class 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010027304 Menopausal symptoms Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 229960003965 antiepileptics Drugs 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000004132 lipogenesis Effects 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/302—Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/2124—Ginseng
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/38—Multiple-step
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
본 발명에서는 산양삼을 특정 조건으로 추출하여 제조한 진세노사이드 Rg1 및 Rb1이 현저히 증진된 산양삼 추출조성물 및 그 제조방법이 개시된다.
본 발명에 따른 산양삼 추출조성물은 진세노사이드 Rg1 및 Rb1을 고함량으로 함유하고 항산화 활성이 우수하여 기능성 식품 및 화장품의 소재로 사용될 수 있다.In the present invention, a wild ginseng extract composition with significantly enhanced ginsenosides Rg1 and Rb1 prepared by extracting wild ginseng under specific conditions and a method for producing the same are disclosed.
The wild ginseng extract composition according to the present invention contains a high content of ginsenosides Rg1 and Rb1 and has excellent antioxidant activity, so it can be used as a material for functional foods and cosmetics.
Description
본 발명은 진세노사이드 Rg1 및 Rb1이 강화된 산양삼 추출조성물 및 그 제조방법에 관한 것으로, 더 상세하게는 산양삼을 특정 조건으로 추출하여 제조한 진세노사이드 Rg1 및 Rb1이 현저히 증진된 산양삼 추출조성물 및 그 제조방법에 관한 것이다.The present invention relates to a wild ginseng extract composition enhanced with ginsenosides Rg1 and Rb1 and a method for producing the same. More specifically, a wild ginseng extract composition with significantly enhanced ginsenosides Rg1 and Rb1 prepared by extracting wild ginseng under specific conditions; and It's about the manufacturing method.
삼(Ginseng)은 재배환경에 따른 인위적인 성장과 자연적인 성장의 차이와 형태학적 차이 등에 따라 인삼(人蔘), 산삼(山蔘), 또는 산양삼(山羊蔘)으로 구분한다. 특히 산양삼은 오가피과에 속하며 다년생 초목인 인삼(Panax ginseng)이 산간의 삼림하의 야생상태에서 자연적으로 성장한 산삼의 씨앗이나 유삼을 인위적으로 산에서 재배한 것을 말하며 이들을 산양삼이라 한다. 인삼의 경우에는 대부분 노두(머리 부분)가 3-7개 정도이나 산양삼은 연령에 따라 그 이상인 것이 많으며 인삼의 뿌리는 굵고 짧으나 산양삼은 길고 가늘다. Ginseng is classified into ginseng, wild ginseng, or wild ginseng according to differences in artificial and natural growth and morphological differences depending on the cultivation environment. In particular, wild ginseng refers to ginseng ( Panax ginseng ), a perennial herb, that belongs to the Eucalyptus family and is artificially cultivated in the mountains from the seeds or ginseng that grew naturally in the wild under mountainous forests. These are called mountain ginseng. In the case of ginseng, there are usually about 3 to 7 outcrops (heads), but sanyangsam often has more than that depending on the age. The roots of ginseng are thick and short, but sanyangsam is long and thin.
사포닌은 식물계에 널리 분포하고 있는 트리텔펜과 스테로이드계 배당체 화합물의 총칭이다. 삼의 사포닌인 진세노사이드(ginsenoside)를 함유한 산양삼은 한약처방전에서 천연 자연 산삼 다음으로 효능을 높이 평가하고 있다. 또한 재배인삼과 비교시 진세노사이드 함량이 높다고 보고되어져 있으며 재배된 인삼보다 효능 또한 뛰어남이 알려져 있다. 그러나 알려진 산양삼 관련 가공품들은 진세노사이드 함유량이 기준치 미달이거나 약리작용이 있은 진세노사이드는 거의 함유되어 있지 않은 실정이다. Saponin is a general term for tritelphene and steroid glycoside compounds that are widely distributed in the plant world. Wild ginseng, which contains ginsenoside, a saponin of ginseng, is highly regarded for its efficacy next to natural wild ginseng in herbal medicine prescriptions. Additionally, it is reported to have a higher ginsenoside content compared to cultivated ginseng, and it is also known to have better efficacy than cultivated ginseng. However, the known processed products related to wild ginseng have a ginsenoside content below the standard or contain almost no ginsenosides with pharmacological effects.
진세노사이드 Rb1는 중추신경에 대한 억제작용을 나타내어 정신안정, 신경이완, 진통, 항경련, 혈압강하, 파파베린양 작용 등을 나타내는 것으로 알려져 있다. 진세노사이드 Rg1은 중추신경에 대해 흥분적으로 작용하여, 항피로작용이 있는 것으로 알려져 있다. 진세노사이드 중 Rg1 및 Rb1은 건강기능식품공전에서 기능성분, 즉 지표 성분으로 지정되어 진세노사이드 Rg1 및 Rb1을 합하여 0.8 내 지 34 mg/g으로 함유되어야 한다고 규정되어 있다. Ginsenoside Rb1 is known to have an inhibitory effect on the central nervous system and to have mental stability, nerve relaxation, analgesic, anticonvulsant, blood pressure lowering, and papaverine-like effects. Ginsenoside Rg1 is known to have an stimulating effect on the central nervous system and to have an anti-fatigue effect. Among ginsenosides, Rg1 and Rb1 are designated as functional ingredients, that is, indicator ingredients, in the Health Functional Food Code, and it is stipulated that the total amount of ginsenosides Rg1 and Rb1 should be contained in 0.8 to 34 mg/g.
알칼리수를 이용하여 홍삼 추출물에서 진세노사이드 Rg1 및 Rb1의 함량을 증가시키는 방법이 개시되어 있으나, 여전히 그 함량이 부족하여 새로운 방법이 개발이 요구되고 있는 실정이다 (등록특허 10-1151722호). A method of increasing the content of ginsenosides Rg1 and Rb1 in red ginseng extract using alkaline water has been disclosed, but the content is still insufficient, so the development of a new method is required (Patent No. 10-1151722).
또한 진세노사이드 Rg1 및 Rb1이 현저히 증진된 산양삼 추출조성물 및 그 제조방법은 개발된 바 없다.In addition, a wild ginseng extract composition with significantly enhanced ginsenosides Rg1 and Rb1 and a method for producing the same have not been developed.
이에 본 발명자들은 종래 기술의 요구에 부응하기 위한 연구를 지속한 결과, 산양삼을 특정 조건으로 추출하여 제조하는 경우, 진세노사이드 Rg1 및 Rb1이 현저히 증진됨을 확인하고 본 발명을 완성하게 되었다.Accordingly, as a result of continuing research to meet the needs of the prior art, the present inventors confirmed that ginsenosides Rg1 and Rb1 were significantly improved when wild ginseng was extracted and manufactured under specific conditions, and completed the present invention.
따라서 본 발명의 목적은 진세노사이드 Rg1 및 Rb1이 강화된 산양삼 추출조성물을 제공하는 것이다.Therefore, the purpose of the present invention is to provide a wild ginseng extract composition enriched with ginsenosides Rg1 and Rb1.
본 발명의 또 다른 목적은 진세노사이드 Rg1 및 Rb1이 강화된 산양삼 추출조성물의 제조방법을 제공하는 것이다.Another object of the present invention is to provide a method for producing a wild ginseng extract composition enriched with ginsenosides Rg1 and Rb1.
본 발명의 또 다른 목적은 본 발명의 산양삼 추출조성물을 포함하는 기능성 식품을 제공하는 것이다.Another object of the present invention is to provide a functional food containing the wild ginseng extract composition of the present invention.
본 발명의 또 다른 목적은 본 발명의 산양삼 추출조성물을 포함하는 화장품을 제공하는 것이다.Another object of the present invention is to provide cosmetics containing the wild ginseng extract composition of the present invention.
상기 목적을 달성하기 위하여, 본 발명은 산양삼을 특정 조건으로 추출하여 제조한 진세노사이드 Rg1 및 Rb1이 증진된 산양삼 추출조성물을 제공한다.In order to achieve the above object, the present invention provides a wild ginseng extract composition with enhanced ginsenosides Rg1 and Rb1 prepared by extracting wild ginseng under specific conditions.
본 발명에서 산양삼은 「산지관리법」제2조 제1호에서 정의하고 있는 산지에서 차광막 등 인공시설을 설치하지 아니하고 생산되는 삼을 칭하는 것으로, 바람직하게는 3년근에서 5년근 사이 재배된 것을 사용한다. In the present invention, wild ginseng refers to ginseng produced in production areas defined in Article 2, Paragraph 1 of the 「Producing Areas Management Act」 without installing artificial facilities such as shading curtains. Preferably, ginseng grown between 3 and 5 years old is used. .
본 발명에서 추출은 80℃ 열수를 이용하여 환류냉각 추출을 수행한다. 추출시간은 2 ~ 4 시간이 바람직하다. In the present invention, extraction is performed under reflux cooling using hot water at 80°C. The extraction time is preferably 2 to 4 hours.
추출시 열수의 양은 산양삼의 20~25배(v/w)를 사용하고, 바람직하게는 20배를 사용한다.During extraction, the amount of hot water used is 20 to 25 times (v/w) that of wild ginseng, preferably 20 times.
상기 추출 조건의 범위를 벗어나면, 진세노사이드 Rg1 및 Rb1 함량의 증진이 미흡하다. Outside the range of the above extraction conditions, the enhancement of ginsenoside Rg1 and Rb1 contents is insufficient.
상기와 같은 특정 조건에서 추출된 본 발명에 따른 산양삼 추출조성물은 놀랍게도 진세노사이드 Rg1 및 Rb1이 현저히 증진되었다 (표 1, 도 1 및 도 2).Surprisingly, the ginsenosides Rg1 and Rb1 were significantly enhanced in the wild ginseng extract composition according to the present invention extracted under the specific conditions described above (Table 1, Figures 1 and 2).
본 발명에 따른 산양삼 추출조성물은 진세노사이드 Rg1을 17.8 mg/g 이상 및 진세노사이드 Rb1를 12 mg/g 이상을 함유하고, 진세노사이드 Rg1과 Rb1를 합하여 30 mg/g 이상 함유한다 (표 1, 도 1 및 도 2). The wild ginseng extract composition according to the present invention contains more than 17.8 mg/g of ginsenoside Rg1 and more than 12 mg/g of ginsenoside Rb1, and more than 30 mg/g of ginsenoside Rg1 and Rb1 combined (Table 1, Figures 1 and 2).
본 발명에 따른 산양삼 추출조성물은, 다른 추출조건들에 비하여, 진세노사이드 Rg1 함량은 최대 약 18배, 진세노사이드 Rb1 함량은 최대 약 13배 증진된다 (표 1, 도 1 및 도 2). Compared to other extraction conditions, the wild ginseng extract composition according to the present invention increases the ginsenoside Rg1 content by up to about 18 times and the ginsenoside Rb1 content by up to about 13 times (Table 1, Figures 1 and 2).
본 발명에 따른 산양삼 추출조성물은 ABTS 라디칼 소거활성이 59.4% 이상 및 DPPH 라디칼 소거활성이 46.7% 이상의 높은 항산화 활성을 갖는다 (도 3 및 도 4).The wild ginseng extract composition according to the present invention has high antioxidant activity with ABTS radical scavenging activity of 59.4% or more and DPPH radical scavenging activity of 46.7% or more (FIGS. 3 and 4).
본 발명의 또 다른 목적을 달성하기 위하여, 본 발명은 클로로젠산 및 루틴이 강화되고 항산화 활성이 증진된 황칠나무 추출조성물의 제조방법을 제공한다. In order to achieve another object of the present invention, the present invention provides a method for producing a Hwangchil tree extract composition with enhanced chlorogenic acid and rutin and improved antioxidant activity.
구체적으로 상기 방법은 Specifically, the method is
ⅰ) 산양삼을 건조하여 분말화하는 단계; 및 i) drying wild ginseng and powdering it; and
ⅱ) 산양삼 분말에 20~25배(v/w)의 80℃ 열수를 혼합하여 환류냉각 추출을 2 ~ 4시간 수행하는 단계를 포함한다.ii) Mixing 20 to 25 times (v/w) 80°C hot water with wild ginseng powder and performing reflux cooling extraction for 2 to 4 hours.
본 발명의 제조방법에서, 산양삼 및 추출은 상기에서 정의된 바와 같다. In the production method of the present invention, wild ginseng and extraction are as defined above.
단계 i) 산양삼 분말 준비Step i) Preparation of wild ginseng powder
산양삼을 건조하여 분말화한다.Wild ginseng is dried and powdered.
산양삼은 흐르는 물에 세척한 후, 물기를 제거하고, 50 ~ 55℃의 드라이오븐에서 이틀간 열풍건조하고 이를 분쇄기로 분쇄하여 80 ~ 100 mesh의 체에 걸러 분말화하였다.Wild ginseng was washed in running water, dried, dried in hot air in a dry oven at 50 to 55°C for two days, pulverized with a grinder, sieved through a sieve of 80 to 100 mesh, and powdered.
상기와 같은 조건으로 분말화시 산양삼으로부터 진세노사이드 Rg1 및 Rb1 을 동시에 증진된 양으로 추출할 수 있다. When powdered under the above conditions, ginsenosides Rg1 and Rb1 can be simultaneously extracted from wild ginseng in increased amounts.
단계 ii) 추출Step ii) Extraction
산양삼 분말에 20~25배(v/w)의 80℃ 열수를 혼합하여 환류냉각 추출을 2 ~ 4시간 수행한다. Mix wild ginseng powder with 20 to 25 times (v/w) 80°C hot water and perform reflux cooling extraction for 2 to 4 hours.
본 발명의 또 다른 목적에 따라서, 본 발명은 상기 제조방법에 의해 제조된 진세노사이드 Rg1 및 Rb1이 증진된 산양산 추출조성물을 포함하는 기능성 식품을 제공한다. According to another object of the present invention, the present invention provides a functional food comprising a goat extract composition with enhanced ginsenosides Rg1 and Rb1 prepared by the above production method.
본 발명에 따른 기능성 식품은 ABTS 라디칼 소거활성 및 DPPH 라디칼 소거활성으로 인하여 우수한 항산화 활성을 갖는다 (도 3 및 도 4). The functional food according to the present invention has excellent antioxidant activity due to ABTS radical scavenging activity and DPPH radical scavenging activity (FIGS. 3 and 4).
본 발명의 또 다른 목적에 따라서, 상기 제조방법에 의해 제조된 진세노사이드 Rg1 및 Rb1이 증진된 산양산 추출조성물을 포함하는 화장품을 제공한다.According to another object of the present invention, there is provided a cosmetic comprising a goat extract composition with enhanced ginsenosides Rg1 and Rb1 prepared by the above production method.
본 발명의 식품 또는 화장품은 본 발명의 추출조성물을 그대로 첨가하거나 다른 식품 또는 화장품 성분과 혼합되어 제조될 수 있고, 통상적인 방법에 따라 적절하게 제조될 수 있다.The food or cosmetic of the present invention can be prepared by adding the extract composition of the present invention as is or mixed with other food or cosmetic ingredients, and can be appropriately manufactured according to conventional methods.
본 발명에서 상기 식품의 종류는 특별히 제한되지 않으며, 환제, 정제, 캡슐제, 차, 음료 (파우치제, 드링크제 등) 등일 수 있으나, 이에 제한되지는 않는다. 화장품의 종류는 마스크팩, 스킨, 로션, 크림 등일 수 있으나, 이에 제한되지는 않는다. In the present invention, the type of food is not particularly limited and may be pills, tablets, capsules, tea, beverages (pouches, drinks, etc.), but is not limited thereto. Types of cosmetics may include mask packs, toners, lotions, creams, etc., but are not limited thereto.
본 발명에 따른 산양삼 추출조성물은 진세노사이드 Rg1 및 Rb1을 고함량으로 함유하고 항산화 활성이 우수하여 기능성식품 및 화장품의 소재로 사용될 수 있다.The wild ginseng extract composition according to the present invention contains a high content of ginsenosides Rg1 and Rb1 and has excellent antioxidant activity, so it can be used as a material for functional foods and cosmetics.
또한 본 발명에 따른 기능성식품 또는 화장품은 진세노사이드 Rg1 및 Rb1의 함량이 높으며, 더불어 우수한 항산화 활성을 가져서, 지방생성 억제효과, 체중 조절, 콜레스테롤 저하, 고지혈증 개선, 동맥경화 완화, 당뇨병 개선, 비만 개선, 혈액순환 개선, 면역력 개선, 피부 미용, 여성 갱년기 증후군 개선용으로 유용하다.In addition, the functional food or cosmetic according to the present invention has a high content of ginsenosides Rg1 and Rb1, and has excellent antioxidant activity, thereby suppressing lipogenesis, controlling body weight, lowering cholesterol, improving hyperlipidemia, alleviating arteriosclerosis, improving diabetes, and obesity. It is useful for improving blood circulation, improving immunity, skin care, and improving female menopausal syndrome.
도 1은 실시예 1의 산양삼 추출조성물의 진세노사이드 HPLC 크로마토그램을 나타낸다.
도 2는 실시예 2의 산양삼 추출조성물의 진세노사이드 HPLC 크로마토그램을 나타낸다.
도 3은 실시예 1 및 실시예 2의 산양삼 추출조성물들의 DPPH 라디칼 소거활성을 나타낸 것이다.
도 4는 실시예 1 및 실시예 2의 산양삼 추출조성물들의 ABTS 라디칼 소거활성을 나타낸 것이다.
도 5는 본 발명에 따른 산양삼 추출조성물을 포함하는 식품(음료)의 일례를 보여주는 사진이다. Figure 1 shows a ginsenoside HPLC chromatogram of the wild ginseng extract composition of Example 1.
Figure 2 shows a ginsenoside HPLC chromatogram of the wild ginseng extract composition of Example 2.
Figure 3 shows the DPPH radical scavenging activity of the wild ginseng extract compositions of Examples 1 and 2.
Figure 4 shows the ABTS radical scavenging activity of the wild ginseng extract compositions of Examples 1 and 2.
Figure 5 is a photograph showing an example of a food (beverage) containing a wild ginseng extract composition according to the present invention.
다음의 실시예들에 의해 본 발명이 더 상세히 설명된다. 이들 실시예는 본 발명을 예시하기 위한 것이며, 본 발명의 범위가 이들에 의해 제한되어서는 안된다.The invention is explained in more detail by the following examples. These examples are intended to illustrate the invention, and the scope of the invention should not be limited by them.
제조예 1: 산양삼 추출조성물 제조 Preparation Example 1: Preparation of wild ginseng extract composition
산양삼은 주식회사 자연애 바이오랩 농업회사법인으로부터 구입하여 사용하였다. Wild ginseng was purchased and used from Jayeonae Biolab Agricultural Corporation.
산양삼 분말 5 g에 물을 100ml 첨가한 후 추출온도를 80℃로 설정하여 각각 2시간 및 4시간 환류냉각장치에서 추출하여 추출조성물을 얻었다 (실시예 1 및 2). After adding 100 ml of water to 5 g of wild ginseng powder, the extraction temperature was set to 80°C and extraction was performed in a reflux cooling device for 2 hours and 4 hours, respectively, to obtain an extract composition (Examples 1 and 2).
비교를 위하여, 추출온도를 각각 70, 75, 85, 90, 95℃로 설정하여 상기와 동일한 방식으로 환류냉각장치에서 추출하여 추출조성물을 얻었다 (비교예 1 내지 10). For comparison, the extraction temperature was set to 70, 75, 85, 90, and 95°C, respectively, and extraction was performed in a reflux cooling device in the same manner as above to obtain an extracted composition (Comparative Examples 1 to 10).
참조예: 분석시료Reference example: analysis sample
제조예에서 제조된 추출조성물 각각을 감압상태에서 여과한 후 60℃에서 3시간 가량 농축하여 농축물을 제조하였고, 각각의 농축물을 HPLC 등급의 water 5 mL에 용해하고 0.45 ㎛ 크기의 필터로 여과한 여액(1 ml)을 분석 시료로 준비하였다.Each of the extract compositions prepared in the preparation example was filtered under reduced pressure and then concentrated at 60°C for about 3 hours to prepare a concentrate. Each concentrate was dissolved in 5 mL of HPLC grade water and filtered through a 0.45 ㎛ filter. One filtrate (1 ml) was prepared as an analysis sample.
시험예 1. 진세노사이드 함량 분석Test Example 1. Ginsenoside content analysis
진세노사이드 분석은 고압액체크로마토그래피(HPLC, high press liquid chromatograph)로 분석하였다. 분석 컬럼은 C18 TSKgel ODS-100Z을 사용하여 시료주입량 20 ㎕, 온도는 30℃, 측정파장은 203 nm, 유속은 1.0 ㎖/min으로 하였고 이동상으로는 A용액은 HPLC water, B용액은 아세토나이트릴을 사용하였다. HPLC 분석 조건은 이동상 용액은 0분때 A용액 100% : B용액 0%로 흘려주고 5분때에는 A용액 80% : B용액 20%로 흘려주고 12분때 A용액 70% : B용액 30%, 45분때 A용액 65% : B용액 35%, 60분때 A용액 10% : B용액 90%, 65분때에 A용액 8% : B용액 92%로 이동상을 흘려주었다. 실시예 1 및 실시예 2의 진세노사이드 HPLC 크로마토그램을 각각 도 1 및 도 2에 나타냈고, 분석된 진세노사이드 Rg1 및 Rb1 함량을 표 1에 나타내었다.Ginsenoside analysis was performed using high press liquid chromatography (HPLC). The analysis column used C18 TSKgel ODS-100Z with a sample injection volume of 20 ㎕, a temperature of 30°C, a measurement wavelength of 203 nm, and a flow rate of 1.0 ㎖/min. The mobile phase used was HPLC water for solution A and acetonitrile for solution B. used. The HPLC analysis conditions are as follows: at 0 minutes, the mobile phase solution is 100% solution A: 0% solution B; at 5 minutes, 80% solution A: 20% solution B; at 12 minutes, 70% solution A: 30% solution B; at 45 minutes, 80% solution A: 20% solution B. The mobile phase was flowed as follows: 65% solution A: 35% solution B, 10% solution A: 90% solution B at 60 minutes, and 8% solution A: 92% solution B at 65 minutes. The ginsenoside HPLC chromatograms of Examples 1 and 2 are shown in Figures 1 and 2, respectively, and the analyzed ginsenoside Rg1 and Rb1 contents are shown in Table 1.
도 1 및 도 2에 나타낸 바와 같이, 본 발명에 따른 실시예 1 및 2의 산양삼 추출조성물에서는 진세노사이드 Rg1 및 Rb1 피크가 현저히 높아진 것을 확인할 수 있다. 또한, 표 1에 나타낸 바와 같이, 실시예 1 및 2의 산양삼 추출조성물은 진세노사이드 Rg1이 각각 17.85 mg/g 및 18.31 mg/g, 진세노사이드 Rb1이 각각 12.22 mg/g 및 13.64 mg/g으로 나타나, 다른 추출조건으로 추출된 비교예 1 내지 비교예 10의 산양삼 추출조성물에 비하여 현저히 증진되었음을 확인할 수 있다. 반면에 열수의 온도가 실시예들에 비하여 5℃ 낮거나 (비교예 3 및 4) 5℃ 높더라도 (비교예 5 및 6) 추출조성물에서 진세노사이드 Rg1 및 Rb1의 함량이 현저히 떨어졌다 (표 1). As shown in Figures 1 and 2, it can be seen that the ginsenoside Rg1 and Rb1 peaks were significantly increased in the wild ginseng extract compositions of Examples 1 and 2 according to the present invention. In addition, as shown in Table 1, the wild ginseng extract compositions of Examples 1 and 2 contained 17.85 mg/g and 18.31 mg/g of ginsenoside Rg1, respectively, and 12.22 mg/g and 13.64 mg/g of ginsenoside Rb1, respectively. It can be seen that it was significantly improved compared to the wild ginseng extract compositions of Comparative Examples 1 to 10 extracted under other extraction conditions. On the other hand, even if the temperature of the hot water was 5°C lower (Comparative Examples 3 and 4) or 5°C higher (Comparative Examples 5 and 6) compared to the examples, the contents of ginsenosides Rg1 and Rb1 in the extracted composition were significantly decreased (Table One).
시험예 2. 항산화 활성 분석Test Example 2. Antioxidant activity analysis
항산화 활성은 DPPH 라디칼 소거활성 및 ABTS 라디칼 소거활성을 측정하여 분석하였다.Antioxidant activity was analyzed by measuring DPPH radical scavenging activity and ABTS radical scavenging activity.
<DPPH 라디칼 소거활성><DPPH radical scavenging activity>
실시예 1 및 실시예 2의 분석시료 각각을 100 ㎕를 96 웰-플레이트에 분주하고, 0.5 mM DPPH 에탄올 용액 (1,1-diphenyl-2-picrylhydrazyl) 50 ㎕를 첨가하여 혼합한 후 25℃에서 30분 동안 반응시킨 후 517 nm에서 흡광도를 측정하였다. DPPH 라디칼 소거활성의 음성 대조구는 시료 대신 PBS를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 다음과 같은 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 3에 도시하였다. Dispense 100 ㎕ of each of the analysis samples of Example 1 and Example 2 into a 96-well plate, add 50 ㎕ of 0.5 mM DPPH ethanol solution (1,1-diphenyl-2-picrylhydrazyl), mix, and incubate at 25°C. After reacting for 30 minutes, absorbance was measured at 517 nm. The negative control for DPPH radical scavenging activity was performed in the same manner using PBS instead of the sample, and the difference in absorbance was calculated as a percentage (%) using the following equation, and the results are shown in Figure 3.
도 3에 나타난 바와 같이, 실시예 1 및 실시예 2의 산양삼 추출조성물의 DPPH 라디칼 소거활성은 각각 46.82% (추출2시간) 및 46.77%(추출 4시간)로 높게 나타났다. As shown in Figure 3, the DPPH radical scavenging activity of the wild ginseng extract compositions of Examples 1 and 2 was high at 46.82% (2 hours of extraction) and 46.77% (4 hours of extraction), respectively.
<ABTS 라디칼 소거활성><ABTS radical scavenging activity>
7 mM ABTS 5ml와 140 mM K2S2O8 (potassium persulfate) 88 ㎕를 혼합한 후 상온에서 암실에서 16시간 반응시켜 ABTS 양이온 용액을 제조하였다. 이 용액을 414 nm에서 흡광도 값이 1.5가 되도록 PBS로 희석하고 조제된 희석용액 190 ㎕와 각각 실시예 1 및 실시예 2의 분석시료 10 ㎕를 혼합한 후 상온에서 6분간 반응시킨 후 734 nm에서 흡광도를 측정하였다. ABTS 라디칼 소거활성의 음성 대조구는 시료 대신 PBS를 사용하여 동일한 방법으로 진행하여 흡광도의 차이를 상기 식에 의해 백분율(%)로 산출하였으며, 그 결과를 도 4에 도시하였다. 7mM ABTS 5ml with 140mM K 2 S 2 O 8 (potassium persulfate) After mixing 88 ㎕, the ABTS cation solution was prepared by reacting for 16 hours in the dark at room temperature. This solution was diluted with PBS so that the absorbance value was 1.5 at 414 nm, mixed with 190 μl of the prepared dilution solution and 10 μl of the analysis samples of Examples 1 and 2, respectively, reacted at room temperature for 6 minutes, and then analyzed at 734 nm. Absorbance was measured. The negative control of ABTS radical scavenging activity was performed in the same manner using PBS instead of the sample, and the difference in absorbance was calculated as a percentage (%) using the above equation, and the results are shown in Figure 4.
도 4에 나타난 바와 같이, 실시예 1 및 실시예 2의 산양삼 추출조성물의 ABTS 라디칼 소거활성은 각각 61.50%(추출 2시간) 및 59.47%(추출 4시간)로 높게 나타났다. As shown in Figure 4, the ABTS radical scavenging activity of the wild ginseng extract compositions of Examples 1 and 2 was high at 61.50% (2 hours of extraction) and 59.47% (4 hours of extraction), respectively.
이들 결과로부터 본 발명에 따른 산양삼 추출조성물은 항산화 활성이 우수함을 알 수 있다.From these results, it can be seen that the wild ginseng extract composition according to the present invention has excellent antioxidant activity.
시험예 3. 이화학적 특성 분석Test Example 3. Physicochemical property analysis
제조예 1에서 제조된 각각의 추출조성물의 pH, 산도 및 가용성 고형물 함량을 분석하였다. pH는 각각의 추출조성물 1 mL에 증류수 49 mL를 비이커에 옮겨 담아 pH meter (MP 200, Jenway, Lodon, UK)를 사용하여 측정하였다. 산도 측정은 pH를 측정한 시료에 0.1 N NaOH 용액으로 pH 값이 8.3±0.2까지 중화시킨 후 젖산 양으로 환산하여 %로 나타내었다. 가용성 고형물은 각 추출조성물 1 mL를 굴절당도계 (Sccharometer, W.S.R.O-90, Atago, Co., Tokyo, Japan)로 당도를 측정하였다. 그 결과를 표 2에 나타냈다. The pH, acidity, and soluble solid content of each extract composition prepared in Preparation Example 1 were analyzed. The pH was measured using a pH meter (MP 200, Jenway, Lodon, UK) by transferring 49 mL of distilled water to 1 mL of each extract composition in a beaker. For acidity measurement, the sample whose pH was measured was neutralized with 0.1 N NaOH solution until the pH value was 8.3 ± 0.2, then converted to the amount of lactic acid and expressed as %. For soluble solids, the sugar content of 1 mL of each extract composition was measured using a refractometer (Sccharometer, W.S.R.O-90, Atago, Co., Tokyo, Japan). The results are shown in Table 2.
본 발명에 따라 제조된 산양삼 추출조성물은 pH는 약간 증가하였고, 산도 및 가용성 고형물은 크게 변화가 없었다. pH가 높을 경우에는 식품위해미생물 등의 증식이 가능하고, 너무 낮을 경우에는 과다 산이 생성되면 신맛이 강화하여 기호성에 문제가 발생할 수 있는데, 본 발명의 산양삼 추출조성물은 적당한 pH와 산도로 기호성이 좋다. The pH of the wild ginseng extract composition prepared according to the present invention slightly increased, and acidity and soluble solids did not change significantly. If the pH is high, the growth of food-harmful microorganisms is possible, and if it is too low, excessive acid is produced, which may enhance the sour taste and cause problems with palatability. The wild ginseng extract composition of the present invention has good palatability with appropriate pH and acidity.
제조예 2: 음료 제조Preparation Example 2: Beverage Preparation
본 발명에 따른 산양삼 추출조성물 (실시예 1)을 이용하여 하기 표 3과 같은 배합비로 혼합하여 음료 제품을 제조하였고, 포장된 제품 사진을 도 5에 나타냈다. A beverage product was prepared by mixing the wild ginseng extract composition (Example 1) according to the present invention at the mixing ratio shown in Table 3 below, and a photograph of the packaged product is shown in Figure 5.
Claims (3)
i) 산양삼은 흐르는 물에 세척한 후, 물기를 제거하고, 50 ~ 55℃의 드라이오븐에서 이틀간 열풍건조하고 이를 분쇄기로 분쇄하여 80 ~ 100 메쉬(mesh)의 체에 걸러 분말화하는 단계;
ii) 산양삼 분말에 20배(v/w)의 80℃ 열수를 혼합하여 환류냉각 추출을 2 시간 수행하여 산양삼 추출조성물을 얻는 단계; 및
iii) 산양삼 추출조성물 96.04 중량%, 산양삼배양근 3.84 중량%, 비타민 C 0.06 중량% 및 자몽종자추출물 0.06 중량%을 혼합하는 단계;를 포함하고,
상기 산양삼 추출조성물은 진세노사이드 Rg1을 17.8 mg/g 이상 및 진세노사이드 Rb1을 12 mg/g 이상 함유하는 것인 제조방법. A method for producing a beverage fortified with ginsenosides Rg1 and Rb1.
i) Washing wild ginseng in running water, removing moisture, drying with hot air in a dry oven at 50 to 55°C for two days, pulverizing it with a grinder, sieving it through a sieve of 80 to 100 mesh, and powdering it;
ii) mixing 20 times (v/w) of 80°C hot water with wild ginseng powder and performing reflux cooling extraction for 2 hours to obtain a wild ginseng extract composition; and
iii) mixing 96.04% by weight of wild ginseng extract composition, 3.84% by weight of wild ginseng cultured roots, 0.06% by weight of vitamin C, and 0.06% by weight of grapefruit seed extract;
A manufacturing method wherein the wild ginseng extract composition contains more than 17.8 mg/g of ginsenoside Rg1 and more than 12 mg/g of ginsenoside Rb1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020240015399A KR102660565B1 (en) | 2020-11-17 | 2024-01-31 | Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200153361A KR20220067075A (en) | 2020-11-17 | 2020-11-17 | Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof |
KR1020240015399A KR102660565B1 (en) | 2020-11-17 | 2024-01-31 | Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200153361A Division KR20220067075A (en) | 2020-11-17 | 2020-11-17 | Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20240019790A KR20240019790A (en) | 2024-02-14 |
KR102660565B1 true KR102660565B1 (en) | 2024-04-25 |
Family
ID=81807750
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200153361A KR20220067075A (en) | 2020-11-17 | 2020-11-17 | Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof |
KR1020240015399A KR102660565B1 (en) | 2020-11-17 | 2024-01-31 | Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200153361A KR20220067075A (en) | 2020-11-17 | 2020-11-17 | Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR20220067075A (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100903161B1 (en) * | 2007-09-21 | 2009-06-17 | 천지영농조합법인 | The beverage of ginseng and its manufacturing method |
KR20150037109A (en) * | 2013-09-30 | 2015-04-08 | 주식회사 함양산양삼 | Manufacturing method of composition of health food containing wild ginseng and herb extracts and composition of health food containing wild ginseng and herb extracts manufactured by the same |
KR102007576B1 (en) * | 2017-11-23 | 2019-08-05 | 경남과학기술대학교 산학협력단 | Beverage composition of Aronia melanocarpa containing active ginsenosides and preparation method thereof |
-
2020
- 2020-11-17 KR KR1020200153361A patent/KR20220067075A/en not_active IP Right Cessation
-
2024
- 2024-01-31 KR KR1020240015399A patent/KR102660565B1/en active IP Right Grant
Non-Patent Citations (2)
Title |
---|
강경명 외 3인, 산양삼의 품질특성 및 항산화 활성에 미치는 영향, 한국식품영양과학회지, 2016, 45(12), 1740-1746. 1부.* |
우리 부모님 건강 챙기는 천종 산삼배양근♬, 네이버 블로그(2020.9.26), 인터넷(https://blog.naver.com/ghtkd0530/222100163686) 1부.* |
Also Published As
Publication number | Publication date |
---|---|
KR20240019790A (en) | 2024-02-14 |
KR20220067075A (en) | 2022-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020278855B2 (en) | Composition for increasing bioavailability and promoting absorption of ginsenosides in black ginseng extract | |
KR100730647B1 (en) | Aged Concentrate of Ginseng Steamed Red, and a Preparation Method Thereof | |
CN101073370A (en) | Blackthorn pear products and its production | |
CN101073433A (en) | Blackthorn pear fruit-juice solid product and its production | |
KR101593618B1 (en) | Composition for improving bioavailability of saponin | |
KR101447486B1 (en) | Method for producing red ginseng water extract with enhanced specific ginsenoside content | |
WO2008147141A1 (en) | A method for preparing novel black-red ginseng and the extract therefrom and the composition comprising the extract isolated therefrom | |
KR102150162B1 (en) | Liquid composition for stick-type container comprising active mountain-cultivated ginseng extract having increased ginsenosides of human body absorption type, and preparation method thereof | |
KR101963046B1 (en) | Composition of processed ginseng having increased ginsenoside compound K, chlorgenic acid and quercetin, and preparation method thereof | |
KR102078178B1 (en) | Method for manufacturing composition using wood-cultivated ginseng and Schisandra chinensis, and composition manufactured by the same | |
KR102660565B1 (en) | Extracted composition of mountain-cultivated ginseng having increased ginsenoside Rg1 and Rb1 and preparation method thereof | |
KR102335208B1 (en) | Immune enhancing liquid composition having increased ginsenosides Rb1, Rg1 and Rg3 and preparation method thereof | |
KR102007576B1 (en) | Beverage composition of Aronia melanocarpa containing active ginsenosides and preparation method thereof | |
KR102132537B1 (en) | Platycodon grandiflorum Liquid composition for stick-type container having increased ginsenosides of human body absorption type, and preparation method thereof | |
KR101811227B1 (en) | Composition for Immune Enhancement, Fatigue Recovery, Physiologically Active, Detoxification Comprising Extracts of Lycium chinence miller, Rubus coreanus Miq. & Schisandra chinensis | |
KR20010077956A (en) | Method and substance for extracting antioxidant from Cynanchum wilfordii and healthful food including the powder or the antioxidant | |
KR20100116919A (en) | Compositions comprising extract from codonopsis lanceolata for preventing or treating obesity, hyperlipidemia or fatty liver | |
KR20200125154A (en) | Composition for improvementing, preventing or treating obesity and metabolic diseases comprising fractions or extract of molokhia leave | |
KR102685945B1 (en) | A functional mixed tea enhanced with betaine, 5-HMF, ginsenoside Rb1, Rg1 and Rg3 and its preparation method | |
KR101440483B1 (en) | Composition for antiaging comprising extract or fraction of Ardisia tinctoria Pit. as an active ingredient | |
KR102712832B1 (en) | A functional mixed tea enhanced with chlorogenic acid and having high antioxidant activity and its preparation method | |
KR20130071113A (en) | Method for preparing of functional beverage with antioxidative activity using lycium barbarum(goji) | |
KR102044607B1 (en) | Tea of whole mountain-cultivated ginseng having increased active ginsenoside, chlorgenic acid and quercetin, and preparation method thereof | |
KR102365198B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume, Polygonum multiflorum Thunberg and mountain ginseng | |
KR20130039470A (en) | Method for extracting ginseng extracts by steamming with rice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |